GOx-Functionalized Platelet Membranes-Camouflaging Nanoreactors for Enhanced Multimodal Tumor Treatment
Ying Du,Shujun Wang,Jianfeng Luan,Meilin Zhang,Baoan Chen,Yanfei Shen
DOI: https://doi.org/10.2147/IJN.S358138
IF: 7.033
2022-07-07
International Journal of Nanomedicine
Abstract:Ying Du, 1, 2 Shujun Wang, 3 Jianfeng Luan, 3 Meilin Zhang, 1, 2 Baoan Chen, 1, 2, &ast Yanfei Shen 2, &ast 1 Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China; 2 School of Medicine, Southeast University, Nanjing, Jiangsu, People's Republic of China; 3 Department of Blood Transfusion, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Baoan Chen, Department of Hematology and Oncology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, 210009, People's Republic of China, Email Yanfei Shen, School of Medicine, Southeast University, Nanjing, Jiangsu, 210009, People's Republic of China, Email Background: Glucose oxidase (GOx)-based starvation therapy is a new cancer treatment strategy. However, the characteristics such as limited curative effect and hypoxic tumor environment hinder its further application seriously. Methods: Herein, doxorubicin (DOX) loaded in hollow mesoporous copper sulfide (HMCuS) nanoparticles assembled with manganese dioxide (HMMD) as nanoshell was prepared. We developed a targeted enhanced cancer treatment method to camouflage HMMD by GOx-functionalized platelet (PLT) membranes (). Results: GOx can be specially transported to the tumor site with PLT membrane for effective starvation treatment. Glucose and oxygen (O 2 ) in the tumor were converted to H 2 O 2 under the catalysis of GOx. HMMD can catalyze H 2 O 2 to produce O 2 and consume glutathione (GSH) in time, which regulates the tumor microenvironment (TME) and improves the adverse conditions of anti-tumor. In addition, DOX encapsulated in HMCuS-MnO 2 release was accelerated from the nanoparticles after the "gatekeeper" MnO 2 is consumed. The study of anti-tumor mechanism shows that the remarkable tumor suppressive ability of comes from the three peaks synergy of starvation treatment, photothermal treatment (PTT), and chemotherapy. This nanoplatform disguised by PLT membrane has significant tumor inhibition ability, good biocompatibility and almost has no side effects in main organs. Conclusion: This work broadens the application mode of GOx and shows the new development of a multi-mode collaborative processing system of nanoplatforms based on cell membrane camouflage. Keywords: glucose oxidase, PLT membrane, nanoparticles, tumor microenvironment, tumor treatment Glucose is the main source of energy for tumor cell proliferation. Cancer cells mainly use glycolysis to replace the phenomenon of aerobic cycles to adapt to higher energy requirements, which is called the Warburg effect. 1 This shift to aerobic glycolysis makes cells more susceptible to cellular glucose supply, which is the principle behind cancer starvation therapy. 2 Glucose oxidase (GOx) can digest glucose to cut off the energy supply and inhibit tumor growth. This is called GOx-based starvation treatment. 3 As a natural protein oxidoreductase, GOx has the advantage of good biocompatibility. In addition, H 2 O 2 produced in glucose consumption increases the level of tumor oxidative stress and can lead to apoptosis. 4–6 However, it is challenging to block the glucose present in the tumor area due to the continuous supply of tumor blood vessels. The therapeutic effect of GOx alone is limited. Therefore, the trend of cancer treatment based on GOx has gradually changed from monotherapy to combined treatment. 7,8 Some studies encapsulated GOx in nanoparticles to achieve multimodal treatment. 9 However, most nanoparticles may still be cleared by the reticuloendothelial system (RES) during blood circulation, resulting in low targeting efficiency. 10 Another point that cannot be ignored is that solid tumors have the characteristics of hypoxia. 11 For this reason, the lack of additional oxygen (O 2 ) supply in the designed nanoreactor will influence the GOx mediated therapeutic effect. 12 In this study, we demonstrated a nanoreactor that combined PLT-GOx and HMMD for the systematic treatment of tumors. Biotin modified GOx (biotin-GOx) is tightly attached to the surface of the platelet (PLT) membrane and forms PLT-GOx through biotin-protein interaction. 13 Hollow mesoporous copper sulfide (HMCuS) nanoparticles with manganese dioxide (MnO 2 ) nanoshell and doxorubicin (DOX) in the core were p -Abstract Truncated-